Biosensors for screening kinase inhibitors

Nikhil Bhalla, Pedro Estrela

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


For successful drug discovery it is important to understand the fundamentals of the underlying causes and consequences of the diseases for which the drug is being developed. One such physiological process in eukaryotic cells is protein phosphorylation, which is the main post-translational modification of proteins responsible for the onset or progression of Alzheimer's disease, diabetes and various cancers. Protein phosphorylation is facilitated by kinases and inhibitors of kinases act as drugs in controlling or curing these diseases by reducing protein phosphorylation. This review discusses the technologies capable of detecting kinase activity and screening candidate compounds to identify novel inhibitors of protein kinases.

Original languageEnglish
Pages (from-to)2470-2481
Number of pages12
JournalCurrent Topics in Medicinal Chemistry
Issue number22
Publication statusPublished (in print/issue) - 1 Sept 2017


  • Biosensors
  • Cancer
  • Drug discovery
  • Protein phosphorylation
  • Screening kinase inhibitors


Dive into the research topics of 'Biosensors for screening kinase inhibitors'. Together they form a unique fingerprint.

Cite this